Biomedical Innograd

The cluster of biomedical technologies of the Skolkovo Foundation has been replenished with 9 residentsFarmvestnik
On December 19, Moscow hosted the X ceremony of awarding the status of a resident of Skolkovo.

The Fund's portfolio was replenished with 30 more new residents, 9 of them entered the biomedical technologies cluster of the Fund.

Among them are the companies: "Bionovation" (a new generation vaccine against viral hepatitis), "Vitacel" (the project "Personalized tissue-engineered biocomposites for the restoration of hard periodontal tissues"), "Hepatera" (a drug for the treatment of chronic hepatitis B and chronic viral hepatitis), "CardioNova" (a drug for the treatment of hyperlipidemia and prevention of atherosclerosis), "Nanochemical technologies" (technologies for quality control and purification of medicines), "RusBIT ex-JAMIS" (software and hardware complex for determining the degree of spread of a malignant tumor using a streaming screening method), "Sante Pharm" (nanoproducts with antiseptic properties), "Pharmag" (elimination of the disadvantages of magnetic hyperthermia and creation of a method of controlled hyperthermia), "IMMUNOMICS" (development of a new class of means to combat infection caused by HIV).

The total number of innograd participants is 304. 91 of them are residents of the biomedical technologies cluster.

Portal "Eternal youth" http://vechnayamolodost.ru
20.12.2011